Silva PGB, Lemos JVM, Borges MMF, do Rêgo TJR, Dantas TS, Leite CHB, Lima MVA, Cunha MPSS, Sousa FB. Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma: Advances in survival in fifteen years of follow up. J Clin Exp Dent. 2021;13(3):e240-9.

doi:10.4317/jced.57477

___________

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. https://doi.org/10.3322/caac.21492 PMid:30207593

2. Am Hartner L. Chemotherapy for oral cancer. Dent Clin North. 2018;62:87-97. https://doi.org/10.1016/j.cden.2017.08.006 PMid:29126496

3. Pignon JP, Le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4-14. https://doi.org/10.1016/j.radonc.2009.04.014 PMid:19446902

4. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952. https://doi.org/10.1056/NEJMoa032641 PMid:15128894

5. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198-1205. https://doi.org/10.1016/j.ijrobp.2012.05.008 PMid:22749632 PMCid:PMC3465463

6. Bourhis J, Mornex F. Biological principles of chemoradiotherapy. Cancer Radiother. 1998;2:657-662. https://doi.org/10.1016/S1278-3218(99)80003-1 PMid:9922768

7. Arcangeli G, Nervi C, Righini R, Creton G, Mirri MA, Guerra A. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol. 1983;1:101-107. https://doi.org/10.1016/S0167-8140(83)80013-9 PMid:6680215

8. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhattacharjee A, et al. Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer. J Clin Oncol. 2019;37:3032-3041. https://doi.org/10.1200/JCO.19.01076 PMid:31539316

9. Huang Y, Wu LL, Xiang RL, Yu GY. Efficacy and Safety of Intro-Arterial Chemotherapy Combined with Radiotherapy on Head and Neck Cancer: A Systematic Review and Meta-Analysis. J Cancer. 2019;10:6233-6243. https://doi.org/10.7150/jca.36478 PMid:31772656 PMCid:PMC6856744

10. Inhestern J, Schmalenberg H, Dietz A, Rotter N, Maschmeyer G, Jungehülsing M, et al. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Ann Oncol. 2017;28:1917-1922. https://doi.org/10.1093/annonc/mdx202 PMid:28498880

11. Dantas TS, Silva PGB, Sousa EF, da Cunha Mdo P, de Aguiar AS, Costa FW, et al. Influence of educational level, stage, and histological type on survival of oral cancer in a Brazilian population: a retrospective study of 10 years observation. Medicine (Baltimore). 2016;95:2314-2324. https://doi.org/10.1097/MD.0000000000002314 PMid:26817864 PMCid:PMC4998238

12. Ellis MA, Graboyes EM, Wahlquist AE, Neskey DM, Kaczmar JM, Schopper HK, et al. Primary surgery vs radiotherapy for early stage oral cavity cancer. Otolaryngol Head Neck Surg. 2017;158:649-659. https://doi.org/10.1177/0194599817746909 PMid:29256326

13. Santos MGC, Nóbrega DRM, Neves GV, Medeiros HCM, Pereira JV, Gomes DQC. Characterization of late diagnosis of oral cancer in a Brazilian city. Rev Cub Estomatolo. 2015;52:40-45.

14. Martins Filho PRS, Santos TDS, Silva LCFD, Piva MR. Oral cancer in Brazil: a secular history of Public Health Policies. RGO. 2014;62:159-164. https://doi.org/10.1590/1981-8637201400020000091688

15. Spiotto MT, Jefferson G, Wenig B, Markiewicz M, Weichselbaum RR, Koshy M. Differences in survival with surgery and postoperative radiotherapy compared with definitive chemoradiotherapy for oral cavity cancer: a national cancer database analysis. JAMA Otolaryngol Head Neck Surg. 2017;143:691-969. https://doi.org/10.1001/jamaoto.2017.0012 PMid:28426848 PMCid:PMC5547927

16. Oliveira ML, Wagner VP, Filho MS, Carrard VC, Hugo FN, Martins MD. A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay. Braz Oral Res. 2015;29:1-8. https://doi.org/10.1590/1807-3107BOR-2015.vol29.0075 PMid:26083090

17. Luna-Ortiz K, Gómez-Pedraza A, Mosqueda-Taylor A. Soft palate preservation after tumor resection with transoral laser microsurgery. Med Oral Patol Oral Cir Bucal. 2013;18:445-448. https://doi.org/10.4317/medoral.18634 PMid:23229273 PMCid:PMC3668871

18. Amar A, Curioni OA, Franzi SA, Sobrinho JA. Treatment of squamous cell carcinoma of the soft palate. Rev Bras Otorrinolaringol. 2004;70:761-764. https://doi.org/10.1590/S0034-72992004000600009

19. Homma A, Onimaru R, Matsuura K, Robbins KT, Fujii M. Intra-arterial chemoradiotherapy for head and neck cancer. Jpn J Clin Oncol. 2016;46:4-12. https://doi.org/10.1093/jjco/hyv151 PMid:26486825

20. Rana M, Iqbal A, Warraich R, Ruecker M, Eckardt AM, Gellrich NC. Modern surgical management of tongue carcinoma-A clinical retrospective research over a 12 years period. Head Neck Oncol. 2011;3:43. https://doi.org/10.1186/1758-3284-3-43 PMid:21955553 PMCid:PMC3197558

21. Kawano S, Zheng Y, Oobu K, Matsubara R, Goto Y, Chikui T, et al. Clinicopathological evaluation of pre-operative chemoradiotherapy with S-1 as a treatment for locally advanced oral squamous cell carcinoma. Oncol Lett. 2016;11:3369-76. https://doi.org/10.3892/ol.2016.4411 PMid:27123119 PMCid:PMC4841072

22. Padma R, Thilagavathi R, Sundaresan S. Survival outcomes of buccal mucosa carcinoma patients with multimodal therapy: An institutional study. Int J Nut Pharmacol Neurol Dis. 2016; 6:76. https://doi.org/10.4103/2231-0738.179967

23. Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, et al. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases. Radiother Oncol. 2014;111:306-310. https://doi.org/10.1016/j.radonc.2014.03.005 PMid:24746571

24. Driemel O, Ettl T, Kölbl O, Reichert TE, Dresp BV, Reuther J, et al. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther Onkol. 2009;185:296-302. https://doi.org/10.1007/s00066-009-1914-y PMid:19440668

25. Balermpas P, Rödel F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S, et al. Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences. Br J Cancer. 2014;111:1509-18. https://doi.org/10.1038/bjc.2014.446 PMid:25093488 PMCid:PMC4200089

26. Park S, Cho Y, Lee J, Koh YW, Kim SH, Choi EC, et al. Survival and functional outcome after treatment for primary base of tongue cancer: a comparison of definitive chemoradiotherapy versus surgery followed by adjuvant radiotherapy. Cancer Res Treat. 2018;50:1214. https://doi.org/10.4143/crt.2017.498 PMid:29281874 PMCid:PMC6192900

27. Trifiletti DM, Smith A, Mitra N, Grover S, Lukens JN, Cohen RB, et al. Beyond positive margins and extracapsular extension: evaluating the utilization and clinical impact of postoperative chemoradiotherapy in resected locally advanced head and neck cancer. J Clin Oncol. 2017;35:1550-1560. https://doi.org/10.1200/JCO.2016.68.2336 PMid:28475848

28. Klug C, Keszthelyi D, Ploder O, Sulzbacher I, Voracek M, Wagner A, et al. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck. 2004;26:224-31. https://doi.org/10.1002/hed.10373 PMid:14999797

29. Crombie AK, Farah C, Tripcony L, Dickie G, Batstone MD. Primary chemoradiotherapy for oral cavity squamous cell carcinoma. Oral Oncol. 2012;48:1014-18. https://doi.org/10.1016/j.oraloncology.2012.03.027 PMid:22516377

30. Santos RC, Dias RS, Giordani AJ, Segreto RA, Segreto HR. Mucositis in head and neck cancer patients undergoing radiochemotherapy. Rev Esc Enferm USP. 2011;45:1338-44. https://doi.org/10.1590/S0080-62342011000600009 PMid:22241190